Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by coyote13on Apr 13, 2018 12:04am
412 Views
Post# 27877524

Strategic Review. Its Time!

Strategic Review. Its Time!All: surely we are ready for a strategic review process? Thomson, Dr SS and others must be tired of watching this show go on and on and on. I know I am. CAD$3 and I'm out. MV down 75% from the high ...plus /minus.

Plenty of of discussion of great science but crappy funding thinking. Maybe. The fail to this point is failing to understand the FDA needs after a year at least of building a process. PLI seems to understand the "fail" now . Why not 18 months ago? Cost us $120 million cash and a multiple on EV. Where is the Board on this issue? Hello.

Buy side investors maybe sniffing at the carcass but most are staying away after years of failed PL promises. I would remind people of one PL's comical quotes... "We are not a poutine shack". There are plenty more .

The Board should sell the co. Mgmt can't deliver on its promises or what the street wants... no more science press releases. Street wants cash flow runway. Not hard to see that ... B of D , PL and BP.

B of D figure it out. Cash outflow of $120 million . Cash in $$$$$$. Mgmt can't seem to figure it out.

Hopefully my rant is cured by May 9.

As always GLTA longs 

Coyote13
Bullboard Posts